Nicardipine retard in the therapy of elderly diabetic hypertensives: Final report of observational study

R. Antonicelli, P. Pagelli, E. Paciaroni

Research output: Contribution to journalArticle

Abstract

Objective: An uncontrolled multicentre study was carried out in 10 hospitals of the Marche Region of central Italy, to evaluate the efficacy and tolerability of 40 mg nicardipine retard in elderly hypertensive patients with diabetes mellitus type II. Design: The study lasted 6 months, single-blind for the first 3 months and open thereafter. The blood pressure criteria were 165 mmHg systolic and/or 95 mmHg diastolic measured at least three times consecutively in untreated patients or after 10 days of drug washout. Patients: All subjects had a proven diagnosis of diabetes mellitus type II and were ≥ 65 years of age. Results: After the first 14 days of active treatment with nifedipine retard at 40 mg/day, supine systolic blood pressure had fallen to 164.3 ± 12.7mmHg and diastolic to 92.2 ± 7.3mmHg (P

Original languageEnglish
JournalJournal of Hypertension
Volume10
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine

Fingerprint Dive into the research topics of 'Nicardipine retard in the therapy of elderly diabetic hypertensives: Final report of observational study'. Together they form a unique fingerprint.

  • Cite this